Roche and Zealand Pharma announced last month that their amylin analog petrelintide elicited a 9% placebo-controlled weight ...
The FDA in July 2025 made publicly available over 200 complete response letters—an initiative that the investment community ...
Approved Thursday via the FDA's Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for ...
The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.
Sanofi’s interim leadership sought on a Thursday earnings call to quell concerns that its sudden defense of Dupixent’s ...
Chief Scientific Officer Pedro Beltran will succeed Eli Wallace as CEO of BridgeBio Oncology Therapeutics, as the board eyes ...
Women and nonwhite racial/ethnic groups are still earning less in the life sciences. An industry consultant discusses the pay ...
This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for ...
The FDA is signaling change, but actual success depends on more than simply bringing in a new leader at the Center for ...
BioSpace is proud to present its NextGen: Class of 2026, a list of the hottest new life sciences companies in the United States. To come up with this list, BioSpace identified companies that announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results